Radioembolization of Hepatic Lesions from a Radiobiology and Dosimetric Perspective
نویسندگان
چکیده
Radioembolization (RE) of liver cancer with (90)Y-microspheres has been applied in the last two decades with notable responses and acceptable toxicity. Two types of microspheres are available, glass and resin, the main difference being the activity/sphere. Generally, administered activities are established by empirical methods and differ for the two types. Treatment planning based on dosimetry is a prerogative of few centers, but has notably gained interest, with evidence of predictive power of dosimetry on toxicity, lesion response, and overall survival (OS). Radiobiological correlations between absorbed doses and toxicity to organs at risk, and tumor response, have been obtained in many clinical studies. Dosimetry methods have evolved from the macroscopic approach at the organ level to voxel analysis, providing absorbed dose spatial distributions and dose-volume histograms (DVH). The well-known effects of the external beam radiation therapy (EBRT), such as the volume effect, underlying disease influence, cumulative damage in parallel organs, and different tolerability of re-treatment, have been observed also in RE, identifying in EBRT a foremost reference to compare with. The radiobiological models - normal tissue complication probability and tumor control probability - and/or the style (DVH concepts) used in EBRT are introduced in RE. Moreover, attention has been paid to the intrinsic different activity distribution of resin and glass spheres at the microscopic scale, with dosimetric and radiobiological consequences. Dedicated studies and mathematical models have developed this issue and explain some clinical evidences, e.g., the shift of dose to higher toxicity thresholds using glass as compared to resin spheres. This paper offers a comprehensive review of the literature incident to dosimetry and radiobiological issues in RE, with the aim to summarize the results and to identify the most useful methods and information that should accompany future studies.
منابع مشابه
Editorial: Radioembolization in the Treatment of Liver Cancer: A Multidisciplinary Approach for Individualized Therapy
Radioembolization has certainly come a long way since its early years of development in Australia and Asia, where the incidence andmortality rates of hepatic malignancies remain among the highest globally (1). Now, a necessary arsenal component of cancer centers worldwide, it has evolved from its original indication for liver tumors, and has shown utility for tumors in other organs as well. In ...
متن کاملMetastatic Malignant Paraganglioma: A Case Report and Review of Literature
Metastasis is a rare presentation of non-secretory paraganglioma. Consequently, there is no standard of care for the treatment of metastatic malignant paraganglioma. The most widely used chemotherapy regimen for non-resectable cases includes cyclophosphamide, vincristine, and dacarbazine (CVD). CVD has been previously studied with variable therapeutic response. However, yttrium-90 (Y90) radioem...
متن کاملInvestigation of lung normal tissue doses in lung tumors radiation therapy using both gated and conventional radiotherapy
Introduction: In radiation therapy of lung tumors, respiratory motion causes target moving, so a larger margin is needed to cover the clinical target volume (CTV). With the margin increasing, a larger volume of normal tissue will be exposed to high-dose. In this study, dosimetric parameters of normal lung tissue were compared between gated and conventional radiotherapy (RT), u...
متن کاملResults confounded by a disregard for basic dose-response radiobiology.
REPLY: We would like to thank Drs. Lam and Smits for their concerns and comments regarding the methodology in our study (1). The aim of our study was to answer the frequently occurring clinical question of whether a patient with low or no 99mTcmacroaggregated albumin (99mTc-MAA) uptake in metastatic lesions should undergo 90Y-radioembolization. The observation in our patient cohort with colorec...
متن کاملCeliac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy
Radioembolization offers a novel way to treat the nonresectable, liver predominant hepatic malignancies with better tumor response and overall progression-free survival rates. Transarterial catheter-based radioembolization procedure involves the hepatic arterial administration of glass- or resin-based beta emitting Yttirum-90 microspheres. Safe delivery of the tumoricidal radiation dose require...
متن کامل